MARKET

AMRN

AMRN

Amarin
NASDAQ
13.80
-0.24
-1.71%
After Hours: 13.80 0 0.00% 19:30 09/11 EDT
OPEN
14.09
PREV CLOSE
14.04
HIGH
14.10
LOW
13.68
VOLUME
49.37K
TURNOVER
--
52 WEEK HIGH
20.90
52 WEEK LOW
12.96
MARKET CAP
291.50M
P/E (TTM)
-10.6129
1D
5D
1M
3M
1Y
5Y
1D
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
NASDAQ · 2d ago
Weekly Report: what happened at AMRN last week (0831-0904)?
Weekly Report · 5d ago
Weekly Report: what happened at AMRN last week (0824-0828)?
Weekly Report · 08/31 09:23
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
Barchart · 08/31 07:15
Amarin analysis links Vascepa adherence to greater, longer-lasting heart benefits
Seeking Alpha · 08/30 16:37
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
Barchart · 08/28 07:15
Weekly Report: what happened at AMRN last week (0817-0821)?
Weekly Report · 08/24 09:23
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
Barchart · 08/24 07:15
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation PLC stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.